Pediatrix Medical Group, Inc. shareholders at the 2026 Annual Meeting elected all director nominees, ratified PricewaterhouseCoopers LLP as auditors, approved executive compensation advisory vote, and approved the Second Amended and Restated 2008 Incentive Compensation Plan increasing shares by 8,000,000.
Key takeaways
Shareholders elected all nine director nominees to serve until 2027 Annual Meeting.
Ratified PricewaterhouseCoopers LLP as independent auditors for 2026 fiscal year.
Approved non-binding advisory vote on 2025 named executive officer compensation.
Approved Second Amended and Restated 2008 Incentive Compensation Plan, adding 8,000,000 shares.
77,330,139 of 83,072,104 shares represented at meeting, constituting quorum.